Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.088,09
0,31%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bio Techne Corporation (TECH) Bio Techne Corporation (TECH) Notizie

TECH

Bio Techne (TECH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TECH
DataOraFonteTitoloSimboloCompagnia
20/11/202413:00PR Newswire (US)BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCESNASDAQ:TECHBio Techne Corporation
14/11/202413:00PR Newswire (US)BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPONASDAQ:TECHBio Techne Corporation
11/11/202423:47PR Newswire (US)UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNASDAQ:TECHBio Techne Corporation
11/11/202413:00PR Newswire (US)BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNASDAQ:TECHBio Techne Corporation
08/11/202423:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TECHBio Techne Corporation
08/11/202413:00PR Newswire (US)BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCESNASDAQ:TECHBio Techne Corporation
07/11/202413:00PR Newswire (US)ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene TherapyNASDAQ:TECHBio Techne Corporation
06/11/202413:00PR Newswire (US)BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETINGNASDAQ:TECHBio Techne Corporation
05/11/202422:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TECHBio Techne Corporation
05/11/202422:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TECHBio Techne Corporation
05/11/202422:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TECHBio Techne Corporation
05/11/202413:00PR Newswire (US)LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCHNASDAQ:TECHBio Techne Corporation
30/10/202411:30PR Newswire (US)BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTSNASDAQ:TECHBio Techne Corporation
30/10/202411:30PR Newswire (US)BIO-TECHNE DECLARES DIVIDENDNASDAQ:TECHBio Techne Corporation
29/10/202412:00PR Newswire (US)ScaleReady Announces a G-Rex® Grant has been awarded to Luminary TherapeuticsNASDAQ:TECHBio Techne Corporation
10/10/202413:00PR Newswire (US)BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTSNASDAQ:TECHBio Techne Corporation
09/10/202413:00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to LIfT BiosciencesNASDAQ:TECHBio Techne Corporation
08/10/202413:00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer InstituteNASDAQ:TECHBio Techne Corporation
07/10/202413:00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. KlebanoffNASDAQ:TECHBio Techne Corporation
26/09/202413:00PR Newswire (US)LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCHNASDAQ:TECHBio Techne Corporation
24/09/202413:00PR Newswire (US)BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETINGNASDAQ:TECHBio Techne Corporation
18/09/202413:00PR Newswire (US)BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORTNASDAQ:TECHBio Techne Corporation
18/09/202413:00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScapeNASDAQ:TECHBio Techne Corporation
17/09/202413:00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to Verismo TherapeuticsNASDAQ:TECHBio Techne Corporation
17/09/202413:00PR Newswire (US)Verismo Therapeutics Awarded a ScaleReady™ G-Rex® GrantNASDAQ:TECHBio Techne Corporation
16/09/202413:00PR Newswire (US)ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR TherapiesNASDAQ:TECHBio Techne Corporation
12/09/202413:04Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TECHBio Techne Corporation
12/09/202413:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TECHBio Techne Corporation
12/09/202413:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TECHBio Techne Corporation
27/08/202413:00PR Newswire (US)ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene MedicineNASDAQ:TECHBio Techne Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TECH

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network